Patients with T1D (n=47,720) or T2D (n=686,158) in 2005 to 2019 ... “Further research is needed to better understand the mechanisms behind the increased hemorrhagic stroke risk in type 1 ...

New research suggests that there may be significant differences in kidney disease among individuals with type 1 diabetes (T1D) vs those with type 2 diabetes (T2D), potentially influencing the risk ...

In a rodent model of type 2 diabetes (T2D), icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and b ...

The study population included 5,823 T1D patients and 156,204 T2D patients over 758,643 visits to outpatient primary care or endocrinology facilities. Participants were aged 46 to 75.

Specifically, her group found that for T2D versus T1D (P<0.001 for both): LOS: 3.81 vs 2.97 days; Hospital charges: Average $40,433 vs $29,873 ...

Type 1.5 diabetes is commonly known as LADA, or latent autoimmune diabetes in adults. This type of diabetes shares characteristics of both type 1 (T1D) and type 2 (T2D) diabetes.

Data were included for individuals with adult-onset T1D (10,184 participants) or type 2 diabetes (T2D; 375,523) in 2001 to 2020 and 509,172 population controls.

Most of those people have T2D, while only about 10% have T1D. Beyond those with diabetes, 1 in 3 people in the United States have prediabetes.

According to the findings from studies involving the technology, significant glycaemic improvements were observed in subjects ...

Other T2D medications, including metformin, Dipeptidyl Peptidase-4 (DPP-4 inhibitors), pramlintide, older generation GLP-1 RAs, and SGLT2 inhibitors, have also been studied in T1D but none have ...

This data suggests that CGM can mitigate the heart-related issue severity in patients with type 1 diabetes (T1D), irrespective of their low blood sugar events or heart disease history.

More than 90% of people with diabetes live with T2D, yet most of the industry's innovation is focused on complicated systems for "power users" with T1D. This leaves people with T2D struggling with ...